Portfolio

Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion’s MAFTEST® reduces the risk of death in comparison with current clinical guidance July 14, 2022
Oculis Strengthens Leading Ophthalmology Pipeline by InLicensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics March 2, 2022
Peptomyc logra 8,6 millones de sus socios y busca más inversores January 18, 2022
binx health Selected as a Top Digital Health Startup that is Transforming the Future of Healthcare — Named to the 2021 CB Insights Digital Health 150 List December 15, 2021
binx health and Student Health Insurer, Wellfleet, Expand Agreement in College Health for In-Dorm and At-Home Access to Testing for Sexually Transmitted Infections (STIs) December 10, 2021

Passeig de Gràcia, 20 2n 3a
08007 Barcelona
+34 682 300 704
alta@altals.com